[Experiences with the symptomatic topical drug Corti-Dynexan in naval dentistry].
D000287:Administration, Topical; D000535:Aluminum / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000766:Anesthesia, Dental; D000779:Anesthetics, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004338:Drug Combinations; D005561:Formates / Q000627:therapeutic use; D005860:Germany, West; D006801:Humans; D008297:Male; D009326:Naval Medicine; D010194:Pancreatin / Q000627:therapeutic use; D010510:Periodontal Diseases / Q000188:drug therapy*; D011239:Prednisolone; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D014449:Tyrothricin / Q000627:therapeutic use
D000700:Analgesics; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D005561:Formates; D000644:Quaternary Ammonium Compounds; D014449:Tyrothricin; D010194:Pancreatin; D011239:Prednisolone; D000535:Aluminum
Marinezahnärztliche Erfahrungen mit dem symptomatischen Lokaltherapeutikum Corti-Dynexan